[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556508":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":23,"centralContacts":28,"locations":34,"responsibleParty":52,"collaborators":12,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":12,"enrollmentInfo":63,"targetDuration":12,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":75,"overallStatus":37,"whyStopped":12,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"University of Leipzig","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard of care","NO_INTERVENTION","Usual care according to current procedure (in patients with post acute coronary syndrome) regarding LDL target level adjustment",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Cholesterol self-measurement","EXPERIMENTAL","Training patients for self-monitoring of cholesterol, with independent monthly measurements and reporting of results to the study team, followed by prompt therapy adjustments",[18],"Other: Cholesterol self-measurement",[20],{"type":6,"name":14,"description":21,"armGroupLabels":22,"otherNames":12},"Patients will be trained to use a device to self-measurement of cholesterol-values monthly. After the measurement they will report their results to study team for ajusting the therapy.",[14],[24],{"name":25,"affiliation":26,"role":27},"Ulrich Laufs, Professor","University Clinik, Clinic for Cardiology Leipzig","STUDY_CHAIR",[29],{"name":30,"role":31,"phone":32,"phoneExt":12,"email":33},"Irina Mueller-Kozarez, Dr.med","CONTACT","03419711732","irina.mueller-kozarez@medizin.uni-leipzig.de",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Clinic of cardiology University clinic Leipzig","RECRUITING","Leipzig","Saxony","04103","Germany","DE",{"type":44,"coordinates":45},"Point",[46,47],12.37129,51.33962,{"lat":47,"lon":46},[50],{"name":51,"role":31,"phone":32,"phoneExt":12,"email":33},"Irina Müller-Kozarez, Dr.med",{"type":53,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR","100556508","cholesterol-self-testing-in-patients-post-acute-coronary-syndrome-100556508",false,"NCT06526013","Cholesterol Self-testing in Patients Post Acute Coronary Syndrome","C-Check","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Patients with acute coronary syndrome in the last 6 months and not having reached the LDL target value\n* Signed informed consent\n\nExclusion Criteria:\n\n* Persons unable to understand the study\n* Persons unable or unwilling to perform self-measurements\n* Persons unable or unwilling to undergo additional cholesterol-lowering therapy to reach the LDL target\n* Pre-menopausal women without contraception\n* Use of experimental drugs or investigational products within 30 days prior to screening\n* Employees or contractors of the institution conducting the study or family members of the Principal Investigator, Co-Investigator, or financial supporter","ALL","18 Years",{"count":64,"type":65},200,"ESTIMATED","INTERVENTIONAL",[68],"NA","The pharmacological reduction of LDL-C lowers cardiovascular risk and is therefore a priority in cardiovascular secondary prevention. The achievement of LDL-C target levels in Germany, Europe, and worldwide is inadequate, despite a wide array of lipid-lowering medications. Only a small proportion of post-myocardial infarction patients reach their LDL-C target range within a year. There is a significant need for new strategies to improve LDL-C target achievement and thereby reduce the occurrence of secondary cardiovascular events.\n\nThe aim of the study is to establish a basis for improving prevention by achieving the target LDL level effectively and quickly in patients with high and very high cardiovascular risk profiles.",[71,72,73,74],"Acute Coronary Syndrome","Prevention","LDL Hyperlipoproteinemia","Therapeutic Adherence",[71,76,77,78,79],"Dyslipidemia","Statin","Lipid lowering therapy","Cardiovascular disease","2024-07-30",{"date":82,"type":83},"2024-08-01","ACTUAL",{"date":85,"type":83},"2024-06-01",{"date":87,"type":65},"2025-09-30",{"name":5,"class":6},1]